The Minister for Health, Wicklow TD, Simon Harris says he has been assured that there will be no delay in accessing the drug Spinraza, following a lengthy campaign by parents of those affected.
The HSE’s leadership team has approved access to the drug for children with type 1, 2 and 3 Spinal Muscular Atrophy on an exceptional and individualised basis.
Earlier this year, the HSE said the drug would cost about €600,000 in the first year to treat each of the 25 Irish children with the disease and €380,000 a year thereafter,.
Spinraza is now approved in 26 countries around Europe with just Estonia rejecting it.
Irish Farming Could Face 'Cliff Edge' With One In Three Farmers Planning Exit
Wicklow's "Irish Viking" Disqualified From Driving for Six Years
Wicklow Whiskey Tariff Relief A 'Gamechanger' For Local Distillers
Teacher Shortage Solution Comes To Wicklow Schools
Hospital Parking Charges Under Fresh Review As Brady Demands Action
